Project Description

Bien

capsules 0,1 g, 0,2 g, 0,4 g – Capsulae Bieni 0,1, 0,2 et 0,4

international nonproprietary name

Not established

Ref

BP-0013

Pharmacotherapeutic group

Agents for gastrointestinal tract pathology treatment. Antiulcer agents. Regenerants and reparants.

Composition of the preparation

1 capsule contains 100, 200 or 400 mg of bien.

Bien is a complex of ethylic ethers of the polyunsaturated fat acids received from lipids of micellar Entomophthora virulenta fungus. Bien consists in 90-95 % of the higher fatty acids. The bien structure includes: ethylic ether  of linolenic acids(w-3),ethylic ether of linoleic acid(w-6),ethylic etherof  g – linolenic acids(w-6),ethylic ether of arachidonic acid(w-6),ethylic ether of eicosanoid acids (w-6),ethylic ether of eicosapentaenoic acid(w-6),ethylic ether of palmitic acid(w-7),ethylic ether of palmitoleic acid(w-9),ethylic ether of oleic acid(w-9),ethylic ether of stearic acid, ethylic ether of myristic acid.

Pharmacological action

Pharmacodynamics

Bien in a complex of pharmacological effects is referred to reparative and cytoprotective agents. The preparation has stimulating influence on wound healing process and burns of skin and mucosa. High efficiency of the preparation has been shown at treatment of peptic ulcer of stomach and duodenum. The bien medical effect is dose-dependent and nonspecific and, consequently, the preparation can be used at others ulcer-necrotic lesions of mucosa. In comparative studies bien exceed antiulcer effect of sea-buckthorn oil and approaches to activity of antisecretory medicinal preparations. Bien is not toxic and at long application does not cause appreciable functional, morphological and biochemical changes in an organism.

Pharmakokinetics

The arachidonic acid is a precursor of biologically active compounds – eicosanoids: diene prostanoids (prostaglandins; prostacyclins, thromboxanes), tetraene leukotrienes; tetraene lipotrienes, lypoxynes, hydroperoxy – and hydroxyeicosapoliene acids.Dihomo-g- linolenic acid throughΔ5-desaturasetransformed into arachidonic acid, or directly participates in synthesis of eicosanoids.a- linolenic acid during a biotransformation formseicosapentaenoic acid anddocosahexaenoic acid, can take part in formation of prostaglandins and leukotrienes through series of intermediate stages. Trienoicprostanoids are formed froma-linolenicacid (prostaglandins; prostacyclins, thromboxanes), pentaene leukotrienes; pentaene lipotrienes, lypoxynes, hydroperoxy – and hydroxyeicosapoliene acids.The linoleic acid is the precursor of monoene prostanoids biosynthesis (зrostaglandins; prostacyclins, thromboxanes), and also trienoic leukotrienes; trienoic lipotrienes, lypoxynes.

Indications 

Bien capsules are administrated for treatment of peptic ulcer of stomach and duodenum, ulcer-necrotic lesions of gastrointestinal tract mucosa, caused by medicinal preparations, acids and alkalis.

The preparation can be used for prophylaxis of ulcerogenic lesion of gastrointestinal tract mucosa in persons, forced to accept nonsteroid antiinflammatory agents for a long time.

special indication

Not established

special warning

Not established

Dosage and method of administration

Bien in capsules is used for treatment of peptic ulcer of stomach and duodenum and other ulcerogenic lesions of gastrointestinal tract mucosa. The preparation is recommended to intake per 0,8-1,2 g3 times a day in 20-30 minutes prior to meal. In case of need the daily dose of the preparation can be increased up to 5,4-8,0 g. Treatment is continued up to healing of mucosa ulcerative defect. The preparation can be administrated together with other antiulcerous agents.

overdosage

There no information about cases of bien in capsules overdosage.

safety measures

It is necessary to use the preparation with care in patients with arthropathies, in persons with increased individual sensitivity to preparations of polyunsaturated fat acids, chronic pancreatitis, diarrhea expressed by disorders of liver function, at gout.

Side effects

At bien application side effects are not determined.

Contraindications

Contraindications to bien application are not established.

Interactions with other medicinal preparations

The preparation can be administrated simultaneously with histamine Н2-receptors blockers, other medical products used in complex therapy of peptic ulcer of stomach and duodenum, cardiovascular agents, antibiotics, analgesics, preparations included in the standard schemes of treatment of wound, ulcer-necrotic lesions of  skin and mucosa, burns and frostbites. The preparation reduces side effect on GIT mucosa of nonsteroid antiinflammatory agents. Bien intake should be carried out not later than in 2 hours prior to application of antacids, sucralfate and other medical products with adsorbing action.

The form of release

Soft gelatinous capsules per 200 mg and 400 mg. 40 or 50 capsules in glass containers, 10 capsules in a blister.